Precautions and Warnings With Olanzapine and Fluoxetine

Who Should Not Take Olanzapine and Fluoxetine?

You should not take olanzapine and fluoxetine if you:
 
  • Are allergic to Symbyax, olanzapine, fluoxetine, or any of the inactive ingredients used in making olanzapine and fluoxetine. Your healthcare provider or pharmacist has a list of the inactive ingredients.
  • Are taking linezolid (Zyvox®) or intravenous methylene blue. Olanzapine and fluoxetine should not be started in people taking linezolid or IV methylene blue, but a person already taking olanzapine and fluoxetine may be given linezolid or methylene blue, if absolutely necessary, and only with very careful monitoring and only if olanzapine and fluoxetine is stopped during treatment.
  • Have taken a monoamine oxidase inhibitor (MAOI) within the past two weeks. Also, you should not take an MAOI if you have taken olanzapine and fluoxetine within the past five weeks. MAOIs include:
 
 
  • Are taking thioridazine (Mellaril®), an antipsychotic medication. Also, do not take thioridazine if you have taken olanzapine and fluoxetine within the past five weeks.
 

Final Thoughts on Precautions and Warnings With Olanzapine and Fluoxetine

There are several situations in which olanzapine and fluoxetine should not be taken, as well as a number of precautions and warnings people should be aware of before taking the medication. However, it is possible that not all of the warnings or precautions were discussed in this article. Therefore, you should talk with your healthcare provider about the specific precautions and warnings with olanzapine and fluoxetine that may apply to you.
 
Healthy Pet, Healthy You

Olanzapine and Fluoxetine (Symbyax)

Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2016 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.